International Journal of Cardiology
Volume 129, Issue 3 , Pages 363-367 , 13 October 2008

Fibrinogen synthesis is increased in cachectic patients with chronic heart failure

  • Klaus K.A. Witte

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Cardiology, Leeds General Infirmary, Great George Street, Leeds, LS1, UK. Tel./fax: +44 113 2787206.
    • ,
  • Sarah J. Ford

      Affiliations

    • Academic Cardiology, University of Hull, UK
    • ,
  • Tom Preston

      Affiliations

    • Isotope Biochemistry Laboratory, Scottish Universities Research and Reactor Centre, East Kilbride, UK
    • ,
  • John D. Parker

      Affiliations

    • Division of Cardiology, Mount Sinai Hospital, Toronto, ON, Canada
    • ,
  • Andrew L. Clark

      Affiliations

    • Academic Cardiology, University of Hull, UK

Received 9 January 2007 ,Revised 23 May 2007 ,Accepted 7 July 2007.

References 

  1. Roubeno R, Kehayias JJ. The meaning and measurement of lean body mass. Nutr Rev. 1991;49:163–175
  2. Anker S, Ponikowski P, Varney S, et al. Wasting as an independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  3. Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet. 2003;361:1077–1083
  4. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J. 2000;21:521–532
  5. Witte KKA, Clark AL. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol. 2002;85(suppl):23–31
  6. Simonini A, Long CE, Dudley GA, Yue P, McElhinny J, Massie BM. Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. Circulation Res. 1996;79:128–136
  7. Riley M, Elborn JS, McKane WR, Bell N, Stanford CF, Nicholls DP. Resting energy expenditure in chronic cardiac failure. Clin Sci. 1991;80:633–639
  8. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased metabolic rate in patients with congestive heart failure. Ann Intern Med. 1994;121:860–862
  9. Obiesan T, Toth MJ, Kendall D. Energy expenditure and symptom severity in men with heart failure. Am J Cardiol. 1996;77:1250–1252
  10. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241
  11. Zhao SP, Zeng LH. Elevated plasma levels of tumour necrosis factor in chronic heart failure with cachexia. Int J Cardiol. 1997;58:257–261
  12. Falconer JS, Fearon KCH, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 1994;219:325–331
  13. Staal van den Brekel AJ, Dentener MA, Schols AMWJ, Buurman WA, Wouter EFM. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol. 1995;13:2600–2605
  14. Wigmore SJ, Plester CE, Ross JA, Fearon KC. Contribution of anorexia and hypermetabolism to weight loss in anicteric patients with pancreatic cancer. Br J Surg. 1997;84:196–197
  15. Blay YJ, Negrier S, Combaret V, Attali S, Goillot E. Serum level of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res. 1992;52:3317–3322
  16. Falconer JS, Fearon KCH, Ross JA, et al. Acute-phase protein response and survival of patients with pancreatic cancer. Cancer. 1995;75:2077–2082
  17. Reeds PJ, Fjeld CR, Jahoor F. Do the differences between the amino acid compositions of acute phase and muscle proteins have a bearing on nitrogen loss in traumatic states?. J Nutr. 1998;124:906–910
  18. Preston T, Slater C, McMillan DC, Falconer JS, Shenkin A, Fearon KCH. Fibrinogen synthesis is elevated in fasted cancer patients with an acute-phase response. J Nutr. 1998;128:1355–1360
  19. Baumann H, Gauldie J. The acute phase response. Immunology Today. 1994;15:74–80
  20. McMillan DC, Slater C, Preston T, Falconer JS, Fearon KCH. Simultaneous measurement of albumin and fibrinogen synthetic rates in normal and fasted subjects. Nutrition. 1996;12:602–607
  21. Slater C, Preston T, McMillan DC, Falconer JS, Fearon KCH. GC/MS analysis of [2H5]-phenylalanine at very low enrichment: measurement of protein synthesis in health and disease. J Mass Spectrom. 1995;30:1325–1332
  22. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr. 1982;36:680–690
  23. Retzlaff JA, Tauxe WN, Kiely JM, Stroebel CF. Erythrocyte volume, plasma volume, and lean body mass in adult men and women. Blood. 1969;33:649–661
  24. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  25. Mayer G, Schomerus H. Synthesis rates of albumin and fibrinogen in patients with cardiac and pulmonary cachexia. Acta Hepatogastroenterol (Stuttg). 1977;24:82–85
  26. Morrison WL, Gibson JN, Rennie MJ. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched-chain amino acid administration. Eur J Clin Invest. 1988;18:648–654
  27. Fearon KC, Barber MD, Falconer JS, McMillan DC, Ross JA, Preston T. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg. 1999;23:584–588
  28. Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer. 2004;101:2727–2736
  29. McMillan DC, Preston T, Watson WS, et al. Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer. Br J Surg. 1994;81:1011–1014
  30. Fearon KC, McMillan DC, Preston T, Winstanley FP, Cruickshank AM, Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg. 1991;213:26–31
  31. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621–636
  32. Preston T, Slater C, McMillan DC, Falconer JS, Shenkin A, Fearon KC. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J Nutr. 1998;128:1355–1360
  33. Norrelund H, Wiggers H, Halbirk M, et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006;260:11–21
  34. Cortes CW, Thompson PD, Moyna NM, et al. Protein kinetics in stable heart failure patients. J Appl Physiol. 2003;94:295–300
  35. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med. 2004;36:518–529
  36. Tracey KJ, Morgello S, Koplin B, et al. Metabolic effects of cachectin/tumour necrosis factor are modified by site of production: cachectin/tumour necrosis factor-secreting tumour in skeletal muscle induces chronic cachexia, while implantation in brain induces predominately acute anorexia. J Clin Invest. 1990;86:2014–2024
  37. Preston T, Fearon KCH, Robertson I, East BW, Calman KC. Tissue loss during severe wasting in lung cancer patients. In:  Ellis KJ,  Yasumura S,  Morgan WD editor. In vivo body composition studies. London, UK: Institute of Physical Sciences in Medicine; 1987;p. 60–69
  38. Grimble RF. Nutrition and cytokine action. Nutr Res Rev. 1990;3:193–210

PII: S0167-5273(07)01707-X

doi: 10.1016/j.ijcard.2007.07.119

International Journal of Cardiology
Volume 129, Issue 3 , Pages 363-367 , 13 October 2008

Article Tools

* Image Usage & Resolution